A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2011
12/08/2011	WO2011151667A1 Antiviral compositions
12/08/2011	WO2011151631A1 Nanoparticles and their uses in molecular imaging
12/08/2011	WO2011151356A2 Methods for the preparation of injectable depot compositions
12/08/2011	WO2011151355A1 Antipsychotic injectable depot composition
12/08/2011	WO2011151087A1 Oral dosage forms of bendamustine
12/08/2011	WO2011151086A1 Oral dosage forms of bendamustine and therapeutic use thereof
12/08/2011	WO2011150505A1 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
12/08/2011	WO2011150494A1 Mitochondrial penetrating peptides as carriers for anticancer compounds
12/08/2011	WO2011150493A1 Mitochondrial penetrating peptides as carriers for antimicrobials
12/08/2011	WO2011150482A1 Methods for obtaining reabsorbable composites, composites, membrane, scaffold and its uses
12/08/2011	WO2011150481A1 Nanoparticulate composition containing antibiotics for intramammary administration in animals
12/08/2011	WO2011128910A3 A drug delivery solid dosage formulation of sirolimus
12/08/2011	WO2011112482A3 Polymeric drug delivery conjugates and methods of making and using thereof
12/08/2011	WO2011058351A3 Pharmaceutical composition
12/08/2011	WO2011042902A3 Microcapsules comprising benzoyl peroxide and topical compositions comprising them
12/08/2011	WO2010124797A8 Anti-mesothelin immunoconjugates and uses therefor
12/08/2011	WO2010120389A8 Polymeric drug delivery systems and processes for producing such systems
12/08/2011	WO2010102148A3 An improved dry powder drug delivery system
12/08/2011	US20110301250 Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use
12/08/2011	US20110301249 Stem cell enhanced protein products and uses therof
12/08/2011	US20110301248 Compositions and methods of delivery of pharmacological agents
12/08/2011	US20110301247 Cosmetic product containing film-forming polymer
12/08/2011	US20110301231 Lipase inhibiting composition
12/08/2011	US20110301230 Gene carrier
12/08/2011	US20110301220 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301219 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301131 Drug Delivery Implants and Processes for Their Preparation
12/08/2011	US20110301129 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
12/08/2011	US20110301100 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110301085 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
12/08/2011	US20110300222 Luminescent porous silicon nanoparticles, methods of making and using same
12/08/2011	US20110300221 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
12/08/2011	US20110300212 Pharmaceutical Formulation
12/08/2011	US20110300210 Controlled release nanoparticulate clozapine compositions
12/08/2011	US20110300162 Drug conjugate composition
12/08/2011	US20110300127 Drug-containing composition
12/08/2011	US20110300126 Dispersion and debundling of carbon nanotubes using gemini surfactant compounds
12/08/2011	US20110300096 Polymers With Structure-Defined Functions
12/08/2011	US20110300094 Silicone Oil-In-Water Emulsions
12/08/2011	US20110300088 Water-insoluble reaction product of a polyamine and an oil-soluble polar modified polymer
12/08/2011	DE102011013341A1 New water-soluble or water swellable polymer comprising amidoalkyl sulfonic-, alkylamide- and crosslinked alkyleneoxy-repeating units, useful e.g. as a thickener, emulsifier, sensory additives, solubilizer, dispersant and lubricant
12/08/2011	CA2801801A1 Novel pharmaceutical compounds
12/08/2011	CA2801645A1 Methods of treatment of pancreatic cancer
12/08/2011	CA2801585A1 Peptide particle formulation
12/08/2011	CA2801535A1 Composition and method for inner ear sensory hair cell regeneration or replacement
12/08/2011	CA2801314A1 Methods of treating bladder cancer
12/08/2011	CA2801292A1 Oral formulations of bipolar trans carotenoids
12/08/2011	CA2801184A1 Peripheral blood sparc binding antibodies and uses thereof
12/08/2011	CA2801157A1 Compositions comprising non-acidic boswellia oil fraction as a bio-enhancer for enhancing the bioavailability of biological agents
12/08/2011	CA2801064A1 Crosslinking of proteins and other entities via conjugates of alpha-haloacetophenones, benzyl halides, quinones, and their derivatives
12/08/2011	CA2800741A1 Mitochondrial penetrating peptides as carriers for anticancer compounds
12/08/2011	CA2800730A1 Mitochondrial penetrating peptides as carriers for antimicrobials
12/08/2011	CA2800641A1 Compositions for injectable in-situ biodegradable implants
12/08/2011	CA2800401A1 Biodegradable lipids for the delivery of active agents
12/08/2011	CA2800281A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	CA2800279A1 Oral dosage forms of bendamustine
12/08/2011	CA2800277A1 Oral dosage forms of bendamustine and therapeutic use thereof
12/08/2011	CA2800153A1 Caged cell penetrating peptide-polymer conjugates for diagnostic and therapeutic applications
12/08/2011	CA2800111A1 Antipsychotic injectable depot composition
12/08/2011	CA2796620A1 Injectable formulation
12/07/2011	EP2392594A1 N-terminally monopegylated polypeptides and process for their preparation
12/07/2011	EP2392378A1 Microneedle device
12/07/2011	EP2392354A1 Finely pulverized pharmaceutical composition
12/07/2011	EP2392353A1 Anti A beta antibody formulation
12/07/2011	EP2392345A2 Hapten-carrier conjugates comprising virus like particles and uses thereof
12/07/2011	EP2392331A1 Nicotine-containing product
12/07/2011	EP2392317A1 Counter-pressure filtration of proteins
12/07/2011	EP2391716A1 Delivery of nucleic acids using cell-penetrating peptides
12/07/2011	EP2391646A1 Crystalline insulin-conjugates
12/07/2011	EP2391636A1 Antibiotic peptides
12/07/2011	EP2391386A1 Oligomer-phenothiazine conjugates
12/07/2011	EP2391373A1 Methods for treating or preventing radiocontrast agent induced kidney injury
12/07/2011	EP2391356A1 Treatment of psoriasis
12/07/2011	EP2391346A1 Solid oral formulations of a pyridopyrimidinone
12/07/2011	EP2391341A2 Resuscitation fluid
12/07/2011	EP2391340A1 Apparatus, method and composition for topical treatment of warts and corns
12/07/2011	EP2391332A2 Matte skin finish compositions
12/07/2011	EP2391216A1 Exogenously triggered controlled release materials and uses thereof
12/07/2011	EP2391215A1 Binding-site modified lectins and uses thereof
12/07/2011	EP1859791B1 Sugar-coated tablet
12/07/2011	EP1857462B1 Polyoxyalkylene derivative
12/07/2011	EP1476138B1 Modified release formulations of at least one form of tramadol
12/07/2011	EP1294770B1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
12/07/2011	EP0515460B2 Docosahexaenoic acid, methods for its production and compounds containing the same
12/07/2011	CN1875973B 一种含N<sub>3</sub>-邻甲苯甲酰基氟尿嘧啶的药物组合物及其脂质体制剂 Containing N <sub> 3 </ sub> - o-benzoyl-fluorouracil pharmaceutical compositions and liposomal formulations
12/07/2011	CN1843504B 一种白蛋白毫微球组合药物及其制备和使用方法 One kind of albumin nanospheres combination of drugs and their preparation and use
12/07/2011	CN1527698B 控释可生物降解的凝胶基质 Controlled release biodegradable gel matrix
12/07/2011	CN102272163A 瘦素和瘦素类似物结合物及其用途 Leptin and analogue conjugates and their use
12/07/2011	CN102272155A 登革热病毒中和抗体及其用途 Dengue virus neutralizing antibodies and uses thereof
12/07/2011	CN102271713A 神经降压肽衍生的分枝肽及其用途 Neurotensin-derived peptides and their use of M.
12/07/2011	CN102271712A 用于将物质递送至生物靶标的组合物和方法 For delivering a substance to a biological target compositions and methods
12/07/2011	CN102271666A 用于向肺脏递送药物的方法和组合物 For delivery of a drug to the lungs of the methods and compositions
12/07/2011	CN102271665A 甾族组合物 Steroidal composition
12/07/2011	CN102271662A 冻干制剂的药物组合物及其制备方法 Lyophilized preparation of pharmaceutical compositions and methods for preparing
12/07/2011	CN102271661A 缓释多颗粒的热熔挤出 Slow release granules hot melt extrusion
12/07/2011	CN102271658A 用于治疗伤口、瘢痕、外科手术后粘连形成的含有透明质酸的组合物 For treating wounds, scars, the composition comprising hyaluronic acid adhesion formation following surgery
12/07/2011	CN102268436A 前列腺癌靶向基因的寡核苷酸适配体、递释载体、递释系统及其制备方法 Prostate cancer gene targeted oligonucleotide aptamers, handed release carrier release delivery system and its preparation method
12/07/2011	CN102268094A Modified transferrin fusion proteins
12/07/2011	CN102268093A 一种肝靶向肽与人干扰素a2b融合蛋白及其制备方法和应用 One kind of liver targeting peptide fusion protein with human interferon a2b its preparation method and application

1 ... 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 ... 1712